Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

ER expenditures for privately insured increased faster than Medicare, Medicaid

Between 1996 and 2015, the number of emergency department (ED) visits per individual paid for by Medicare increased at a greater rate than those paid for by private insurance or Medicaid. The annual increases in per-visit expenditures, however, were greater for private insurance than either of the federal programs.

4 marketing strategies to improve patient engagement

Improving patient engagement by utilizing Google products and engaging on social media could lead to improved outcomes, according to a blog post by DocASAP.

Thumbnail

‘Enough is enough': Hospitals bash new Medicare changes proposed in Trump’s budget

The budget proposed by President Donald Trump involves several major cuts to Medicare payments for hospitals, reductions that are “unsustainable” and “staggering,” according to the Federation of American Hospitals (FAH) and the American Hospital Association (AHA).

Hospital price growth hit 4-year high in Dec. 2017

An era of low inflation in healthcare prices may be winding down, judging by the results of Altarum’s latest health sector economic indicator reports, which said hospital prices grew by 2.2 percent in December 2017, the fastest growth rate in four years.

Aetna under investigation after medical director said he never looked at patient records

The California Department of Insurance is now examining Aetna’s claims denial process after a former medical director for the insurer’s Southern California operations, Jay Ken Iinuma, MD, said under oath that he never looked at a patient’s health record when deciding whether to approve a deny a claim.

Trump budget would cut $675B in healthcare spending by 2028

The fiscal year 2019 budget proposal from President Donald Trump’s administration would cut nearly $18 billion in funding to HHS, while relying on repealing the Affordable Care Act (ACA) and turning Medicaid into a state-administered block grant program to reduce healthcare spending by the federal government by $675 billion by 2028.

UCSF envisions new hospital after $500M donation

The University of California, San Francisco (UCSF) received a $500 million commitment from the Helen Diller Foundation to help plan and build a new hospital, according to a Feb. 8 release from the university.

5 questions about healthcare ahead of Trump budget proposal

President Donald Trump is expected to release a budget proposal Monday, Feb. 12. This move is more of a wish list from the chief executive, because Congress controls federal spending, but the budget can convey priorities and policy ideas.

Displaying 3801 - 3808 of 6652

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup